IMM-20059 is a humanized IgG1 monoclonal antibody specifically targeting EPN1. When used in conjunction with Atezolizumab, IMM-20059 has demonstrated a significant enhancement in tumor regression within the B16.F10 syngeneic melanoma model, surpassing the efficacy observed with anti-PD-L1 monotherapy. This product is pivotal for research focused on innovative cancer treatment modalities and the exploration of synergistic therapeutic combinations.
IMM-20059 is a humanized IgG1 monoclonal antibody specifically targeting EPN1. When used in conjunction with Atezolizumab, IMM-20059 has demonstrated a significant enhancement in tumor regression within the B16.F10 syngeneic melanoma model, surpassing the efficacy observed with anti-PD-L1 monotherapy. This product is pivotal for research focused on innovative cancer treatment modalities and the exploration of synergistic therapeutic combinations.
This calculator helps you calculate mass of compound based on solution concentration, volume and molecular weight in a specific solution using the formula:
